Ignite Creation Date:
2025-12-24 @ 5:45 PM
Ignite Modification Date:
2025-12-28 @ 11:25 AM
Study NCT ID:
NCT04681768
Status:
COMPLETED
Last Update Posted:
2025-09-26
First Post:
2020-12-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Abemaciclib in Combination With Endocrine Therapy as First Line Therapy in Metastatic Breast Cancer Patients
Sponsor:
Technical University of Munich
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-18
First Submit QC Date:
None
Study First Post Date:
2020-12-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-22
Last Update Post Date:
2025-09-26
Last Update Post Date Type:
ESTIMATED